Avenir Wellness Solutions (AVRW) 10-Q2022 Q1 Quarterly report

Filed: 16 May 22, 4:34pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: aa, aftermath, alleging, behavior, Bell, Berlent, billed, chattel, civil, County, Court, dealer, Dov, Forbearance, forecasted, hospital, identification, introduce, John, Jonathan, judicial, largest, layer, lender, macroeconomic, medium, past, referenced, rescission, roll, Sear, Super, supplier, Szapiro, Szaprio, TDR, thereof, tort, Troubled, uncollectible, unlicensed, unregistered, Ventura, Vintage, violation

Removed: acceleration, achievable, acquire, added, aimed, anniversary, attendance, attestation, auditor, bad, battle, bioscience, borrower, broader, call, cancelled, Certificate, chemical, Clarifying, cleaning, collaborate, collateral, collectability, committing, community, complement, comply, conducting, confidence, consistent, constrained, constructive, contemplated, Controller, Cosmetic, decision, declared, deflation, detailed, deteriorate, discontinue, discontinuing, discouraging, discretionary, disposable, disrupt, disruption, distancing, downturn, dramatically, effected, eligible, emerge, emerging, employed, encouraged, endocannabinoid, epidemic, escrow, escrowed, executed, executing, execution, expand, expanding, expert, feasibility, force, forgivable, forma, fourth, front, functional, functioning, generating, globe, Gordon, Hereinafter, hired, homecare, impacting, impair, Incorporation, increasingly, incremental, industrial, inflation, informational, infrastructure, instability, intercompany, investee, investigating, Ionic, irrevocable, Jessica, July, Jumpstart, knowledge, lapse, led, lifecycle, LLC, long, mandated, mandatory, margin, marked, masking, medicine, Memorandum, midway, mitigation, monetization, NDA, nutrition, operation, operational, opt, Oversight, partially, participate, pathway, paycheck, PCAOB, penalty, Pharm, planning, political, power, practicable, pre, precautionary, predicted, privately, pro, projection, prolonged, promote, promoting, proposed, prospectively, qualifying, receiving, reclassification, reclassified, reconciliation, recovery, reformulating, remain, remained, remotely, removing, resignation, retrospective, returned, reverse, revised, revisit, rose, rotation, Rousset, sector, significance, situation, social, specialty, spending, spread, stockholder, study, summarizing, supplement, supply, symptomatic, synergistic, temporarily, transition, transmission, travel, twelve, unclear, undertook, unfavorable, venture, weak, weakening, whichever, wider, widespread, worldwide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AVRW similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S. C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CURE Pharmaceutical Holding Corp., (the “Company”) on Form 10-Q for the period ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Redard, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

	(1)	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: May 16, 2022	By:	/s/ Michael Redard
		Michael Redard
		Chief Financial Officer